Related Experiment Video
Updated: Feb 3, 2026

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
Published on: November 23, 2012
The association of 18F-FDG PET/CT and biomarkers in confirming coronary microvascular dysfunction
Henry Anselmo Mayala1, Khamis Hassan Bakari2, Abdalah Mkangala2
1Department of Cardiology 10th Floor, Wuhan Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, 501 Building, Hankou, Wuhan, 43000, Hubei Province, China. mayalahenry29@gmail.com.
Objective:
The purpose of this study is to evaluate the association between PET/CT CFR and biomarkers combined in confirming the diagnosis of coronary microvascular dysfunction.
Results:
A total of 28 patients (21 males and 7 females) were included in this descriptive observational study (both qualitative and quantitative). The mean patient age was 55.50 ± 10.21 years (range 27-70 years) and the median was 56.5 years (range 49-63 years). All patients underwent Echo, CAG and PET/CT scan. Chest tightness was the most common symptom in our study. Most patients had normal blood pressure (n = 18, 64.3%) while only (n = 10, 37.5%) had hypertension, and (n = 1, 3.6%) had diabetes mellitus. The mean HDL in CMVD (n = 25) and non-CMVD (n = 3) were 1.30 ± 0.39 and 1.08 ± 0.95, respectively, indicating that the difference between the groups was statistically significant (p = 0.04). Similarly, the mean HBA1c- (glycated haemoglobin) in CMVD (n = 25) and non-CMVD (n = 3) were 5.6 ± 0.53 and 5.0 ± 0.26, respectively, with (p = 0.03). Our findings managed to show the association between biomarkers and PET/CT CFR in confirming the diagnosis of coronary microvascular dysfunction.
Insights
This study found that combining PET/CT CFR with specific biomarkers aids in diagnosing coronary microvascular dysfunction. These findings highlight a potential new approach for identifying this cardiovascular condition.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Biomarkers
Background:
- Coronary microvascular dysfunction (CMVD) diagnosis can be challenging.
- Non-invasive imaging and biomarker assessment are crucial for accurate diagnosis.
Purpose of the Study:
- To evaluate the combined diagnostic utility of Positron Emission Tomography/Computed Tomography (PET/CT) derived Coronary Flow Reserve (CFR) and established biomarkers for CMVD.
- To determine the association between PET/CT CFR and biomarkers in confirming CMVD.
Main Methods:
- Descriptive observational study including 28 patients (21 males, 7 females).
- Patients underwent echocardiography, coronary angiography (CAG), and PET/CT scan.
- Analysis included assessment of HDL and HbA1c levels in relation to CMVD status.
Main Results:
- Statistically significant differences were observed in High-Density Lipoprotein (HDL) levels (p=0.04) and Glycated Hemoglobin (HbA1c) levels (p=0.03) between patients with and without CMVD.
- The study demonstrated an association between PET/CT CFR and these biomarkers in confirming CMVD diagnosis.
Conclusions:
- PET/CT CFR combined with specific biomarkers shows promise in confirming the diagnosis of coronary microvascular dysfunction.
- This integrated approach may improve diagnostic accuracy for CMVD.
Related Concept Videos
Confirmation Biases
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Radiological Investigation I: X-ray and CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...

